HUP9903420A3 - Use of fluconazole for the preparation of pharmaceutical compositions, inhibiting the growth of cancers and treating viral infections - Google Patents

Use of fluconazole for the preparation of pharmaceutical compositions, inhibiting the growth of cancers and treating viral infections

Info

Publication number
HUP9903420A3
HUP9903420A3 HU9903420A HUP9903420A HUP9903420A3 HU P9903420 A3 HUP9903420 A3 HU P9903420A3 HU 9903420 A HU9903420 A HU 9903420A HU P9903420 A HUP9903420 A HU P9903420A HU P9903420 A3 HUP9903420 A3 HU P9903420A3
Authority
HU
Hungary
Prior art keywords
fluconazole
cancers
inhibiting
growth
preparation
Prior art date
Application number
HU9903420A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/674,180 external-priority patent/US5908855A/en
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of HUP9903420A2 publication Critical patent/HUP9903420A2/hu
Publication of HUP9903420A3 publication Critical patent/HUP9903420A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9903420A 1995-08-04 1996-07-30 Use of fluconazole for the preparation of pharmaceutical compositions, inhibiting the growth of cancers and treating viral infections HUP9903420A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US188995P 1995-08-04 1995-08-04
US08/674,180 US5908855A (en) 1996-07-16 1996-07-16 Compositions for treating viral infections
PCT/US1996/012474 WO1997005873A2 (en) 1995-08-04 1996-07-30 Use of fluconazole for inhibiting the growth of cancers

Publications (2)

Publication Number Publication Date
HUP9903420A2 HUP9903420A2 (hu) 2000-03-28
HUP9903420A3 true HUP9903420A3 (en) 2001-12-28

Family

ID=26669622

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903420A HUP9903420A3 (en) 1995-08-04 1996-07-30 Use of fluconazole for the preparation of pharmaceutical compositions, inhibiting the growth of cancers and treating viral infections

Country Status (18)

Country Link
EP (1) EP0841921A2 (xx)
JP (1) JPH11510187A (xx)
KR (1) KR19990036138A (xx)
CN (1) CN1195288A (xx)
AR (1) AR003175A1 (xx)
AU (1) AU711966B2 (xx)
BR (1) BR9609966A (xx)
CA (1) CA2229024A1 (xx)
CZ (1) CZ33798A3 (xx)
HU (1) HUP9903420A3 (xx)
IL (1) IL123095A0 (xx)
MX (1) MX9800998A (xx)
NO (1) NO980473L (xx)
NZ (2) NZ503921A (xx)
PL (1) PL324904A1 (xx)
SK (1) SK14198A3 (xx)
TR (2) TR199800270T1 (xx)
WO (1) WO1997005873A2 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
FR2742405B1 (fr) * 1995-12-13 1998-02-27 Cgea Comp Gen Entre Auto Unite motrice susceptible d'etre accouplee a une enceinte roulante et vehicule resultant
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
WO2000027428A1 (en) * 1998-11-09 2000-05-18 Idec Pharmaceuticals Corporation Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-cd20 antibody
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US7004915B2 (en) * 2001-08-24 2006-02-28 Kci Licensing, Inc. Negative pressure assisted tissue treatment system
EP1895012A1 (en) 2006-08-30 2008-03-05 Universitätsklinikum Freiburg Method for inducing tumor apoptosis by increasing nitric oxide levels
US20120071539A1 (en) * 2006-12-12 2012-03-22 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
WO2019185521A1 (en) * 2018-03-26 2019-10-03 Westfälische Wilhelms-Universität Münster Ergosterol-biosynthesis inhibitor and influenza virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196855A3 (en) * 1985-03-29 1989-04-12 Pfizer Inc. Tioconazole and related compounds for prevention of sexually transmitted diseases and control of herpetic infections
BE1004029A6 (nl) * 1990-11-22 1992-09-08 Mol Omer De Farmaceutische samenstelling en farmaceutische set voor het behandelen van kanker.
US5565478A (en) * 1994-03-14 1996-10-15 The United States Of America As Represented By The Department Of Health & Human Services Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Also Published As

Publication number Publication date
HUP9903420A2 (hu) 2000-03-28
IL123095A0 (en) 1998-09-24
TR199800270T1 (xx) 1998-05-21
JPH11510187A (ja) 1999-09-07
SK14198A3 (en) 1999-03-12
NO980473L (no) 1998-04-03
BR9609966A (pt) 1999-02-02
CN1195288A (zh) 1998-10-07
PL324904A1 (en) 1998-06-22
MX9800998A (es) 1998-04-30
EP0841921A2 (en) 1998-05-20
AR003175A1 (es) 1998-07-08
CZ33798A3 (cs) 1998-06-17
NO980473D0 (no) 1998-02-03
TR199801739T2 (xx) 1998-12-21
NZ315184A (en) 2000-05-26
WO1997005873A3 (en) 1997-03-27
AU711966B2 (en) 1999-10-28
CA2229024A1 (en) 1997-02-20
AU6683396A (en) 1997-03-05
KR19990036138A (ko) 1999-05-25
NZ503921A (en) 2002-03-01
WO1997005873A2 (en) 1997-02-20

Similar Documents

Publication Publication Date Title
HUP9903420A3 (en) Use of fluconazole for the preparation of pharmaceutical compositions, inhibiting the growth of cancers and treating viral infections
IL117873A0 (en) Pharmaceutical compositions for inhibiting the growth of viruses and cancers
HUP0001170A3 (en) Pharmaceutical compositions containing benzimidazole-2-carbamate derivatives as active ingredients for the treatment of viral infections and cancer
IL117876A0 (en) Pharmaceutical compositions for inhibiting the growth of viruses and cancers
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
HUP9901243A3 (en) Quinazoline derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds
IL117598A (en) Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9701596A3 (en) 2,4-diamino-1,3,5-triazine derivatives, process for their preparation, their use for the preparation of pharmaceutical compositions and the pharmaceutical compositions containing them
IL117957A0 (en) Pharmaceutical compositions for the treatment of impotence
ZA962879B (en) A pharmaceutical composition for inhibiting the growth of viruses and cancers
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
HUP9601176A3 (en) Amidine derivatives having adhesion-receptor antagonistic effect, pharmaceutical compositions containing the same and process for their preparation
ZA962878B (en) A pharmaceutical composition for inhibiting the growth of viruses and cancers
IL123094A0 (en) Pharmaceutical compositions containing griseofulvin for inhibiting the growth of cancers
HUP9901326A3 (en) Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions
HUP9900901A3 (en) A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
HUP9901485A2 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
ZA962880B (en) A pharmaceutical composition for inhibiting the growth of viruses and cancers
HUP9802634A3 (en) Use of benzimidazoles for the manufacture of pharmaceutical compositions for the treatment of leukemia
HUP0003219A3 (en) Phthalazine derivatives, process for producing them and pharmaceutical compositions containing them and use of the compounds for producing pharmaceutical compositions useful for treating erectile dysfunction
AU4985596A (en) Novel aroylaniline derivatives, compositions and uses thereof in the treatment of viral infections
HUT76052A (en) Azole derivatives having adhesion-receptor antagonistic effect, process for their preparation and pharmaceutical compositions containing the same
HUP9601680A3 (en) Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds
EP0558961A3 (en) Glycopeptide derivatives, process for their manufacture and pharmaceutical compositions comprising them
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions